High-dose grass pollen allergen (Allergopharma)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHigh-dose grass pollen allergen (Allergopharma)
Drug Alias NameAllerslit forte
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityConjunctivitis, AllergicConjunctivitis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergopharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsHypersensitivityConjunctivitis, AllergicConjunctivitis +[4

Other Information

ATC CodeN/A
Related LinksN/A